Heparin-Induced Thrombocytopenia in Patients Suffering Cardiogenic Shock
2024; Wolters Kluwer; Volume: 6; Issue: 7 Linguagem: Inglês
10.1097/cce.0000000000001117
ISSN2639-8028
AutoresEnzo Lüsebrink, Hugo Lanz, Leonhard Binzenhöfer, Sabine Hoffmann, Julia Höpler, Marie Kraft, Nils Gade, Jonas Gmeiner, Daniel Roden, Inas Saleh, Christian Hagl, Georg Nickenig, Steffen Maßberg, Sebastian Zimmer, Raúl Nicolás Jamin, Clemens Scherer,
Tópico(s)Acute Myocardial Infarction Research
ResumoCardiogenic shock (CS) is associated with high mortality. Patients treated for CS mostly require heparin therapy, which may be associated with complications such as heparin-induced thrombocytopenia (HIT). HIT represents a serious condition associated with platelet decline and increased hypercoagulability and remains a poorly researched field in intensive care medicine. Primary purpose of this study was to: 1) determine HIT prevalence in CS, 2) assess the performance of common diagnostic tests for the workup of HIT, and 3) compare outcomes in CS patients with excluded and confirmed HIT.
Referência(s)